Desquamative gingivitis differential diagnosis: a guide for clinicians

What does desquamative gingivitis look like?

Desquamative gingivitis describes gingival redness, epithelial peeling, blistering or shallow erosions. An erosion is a surface break in the lining. Patients may report burning, bleeding with brushing and difficulty eating, while intact blisters may be absent because they rupture quickly.

Suspect an underlying mucosal disorder when inflammation extends across attached gingiva, appears disproportionate to plaque, or persists despite appropriate periodontal care. Plaque-related inflammation can coexist and amplify symptoms; its presence does not exclude immune-mediated disease.

The diagnostic task is to identify the cause, not simply label the appearance. Persistent or recurrent gingival peeling needs an in-person examination because photographs cannot assess tissue firmness, subtle blistering, periodontal findings or extraoral involvement.

• ·Map distribution: localised or generalised, symmetrical or asymmetrical, marginal or attached gingiva.
• ·Record erosions, intact blisters, white lines, ulcers and spontaneous bleeding.
• ·Document pain, oral intake and whether brushing has become difficult.
• ·Do not assume that all red gingiva represents periodontal disease.

What examination sequence narrows the differential?

Begin with symptom duration, recurrence, progression and previous investigations. Review skin disease, autoimmune conditions, current and recently changed prescribed treatments, oral-care exposures, dental materials and tobacco or areca-nut use without assuming any single exposure explains the lesions.

Ask specifically about eye redness, grittiness, watering, visual change, skin blisters, nasal crusting, hoarseness, painful swallowing and genital symptoms. Patients may not connect these findings with their gums.

Examine the entire oral lining, lips and accessible oropharynx, then palpate suspicious lesions and cervical lymph nodes. Assess plaque, periodontal support and local trauma gently; record photographs with consent and a lesion map for comparison.

• ·Look for fine white lines on the cheeks and tongue that support a lichenoid disorder.
• ·Look for widespread fragile erosions that raise suspicion of pemphigus.
• ·Check for localised induration, meaning abnormal firmness, or a persistent focal ulcer.
• ·Record a Nikolsky sign if evident: epithelial separation with gentle pressure. It is not disease-specific, and repeated deliberate provocation adds trauma.
• ·Assess hydration, nutritional impact and ability to swallow before planning outpatient investigation.

When should oral lichen planus or a lichenoid lesion lead the differential?

Oral lichen planus is an immune-mediated inflammatory disorder of the oral lining. Erosive disease may present as painful desquamative gingivitis, with fine white intersecting lines around red or eroded areas.

Bilateral cheek involvement and a broadly symmetrical pattern support the diagnosis. However, gingival disease can occur without obvious characteristic changes elsewhere, and clinical appearance alone may overlap with blistering disorders.

A lichenoid lesion resembles lichen planus but may have a different trigger or distribution. Local contact relationships, treatment history and asymmetry are relevant clues, not proof of causation. Clinicopathological correlation—matching examination findings with the tissue report—is central to diagnosis [3].

• ·Biopsy atypical, isolated, persistent or diagnostically uncertain lesions.
• ·Consider direct immunofluorescence when blistering disease remains a realistic alternative.
• ·Do not attribute a new firm area, persistent focal ulcer or changing red-white lesion to established lichen planus without reassessment.
• ·Arrange long-term clinical surveillance; revisit the diagnosis when the pattern changes.

When should mucous membrane pemphigoid be suspected?

Mucous membrane pemphigoid is an autoimmune blistering disorder in which separation occurs beneath the surface epithelium. Desquamative gingivitis may be its main oral presentation. Relatively intact blisters can occur, but many patients show only erosions.

The major safety issue is disease beyond the mouth. Eye involvement can scar, while laryngeal involvement—the voice-box region—can threaten the airway. Oral severity does not reliably indicate the severity at another site.

The European S3 guideline supports diagnosis through compatible clinical findings and immunopathological testing, meaning tests that identify immune deposits or circulating antibodies [1]. A normal-looking oral examination outside the gingiva does not exclude disease elsewhere.

• ·Ask about eye symptoms at the first visit and during follow-up.
• ·Arrange prompt ophthalmology assessment for suspected or confirmed disease, including patients without obvious eye complaints.
• ·Eye pain, redness, light sensitivity or visual change requires same-day ophthalmic assessment.
• ·New hoarseness, swallowing difficulty or breathing symptoms requires urgent assessment of possible airway involvement.

When should pemphigus vulgaris be suspected?

Pemphigus vulgaris is an autoimmune disorder that disrupts attachment between epithelial cells. Its blisters are fragile, so examination often reveals irregular, painful erosions rather than intact blisters.

Oral lesions can precede skin involvement. Extensive erosions affecting several oral sites, marked tenderness and epithelial fragility should raise suspicion even when the patient reports no skin disease.

International expert recommendations support combining clinical assessment, routine tissue examination and immune-based testing [2]. Desquamative gingivitis alone cannot distinguish pemphigus from pemphigoid, and a positive Nikolsky sign cannot make that distinction.

• ·Refer suspected pemphigus promptly to oral medicine and dermatology.
• ·Escalate to hospital assessment for extensive skin loss, systemic illness or inability to maintain oral intake.
• ·Avoid repeated treatment for presumed plaque-related gingivitis while erosions continue to spread.
• ·Interpret the biopsy and antibody findings together rather than relying on one result.

What other conditions can mimic desquamative gingivitis?

The differential should widen when the distribution, time course or associated findings do not fit the three principal disorders. Acute onset, a strong exposure relationship, focal disease or unusual tissue enlargement may point elsewhere.

Rare blistering diseases cannot reliably be separated by oral appearance alone. Oral medicine, dermatology and a laboratory experienced in immune-mediated mucosal disease may need to coordinate additional testing.

• ·Plaque-related gingivitis or periodontitis: correlate inflammation with deposits, pocketing and attachment loss, while allowing for coexisting mucosal disease.
• ·Contact or irritant reactions: consider a recent oral-care exposure, chemical injury or a local relationship to dental material.
• ·Plasma cell gingivitis: often appears as striking red, swollen gingiva; tissue assessment and exposure history help distinguish it.
• ·Lupus-related oral disease: consider accompanying skin or systemic features and obtain specialist correlation.
• ·Other autoimmune blistering disorders: these include linear IgA disease, named for an immune protein deposited in a linear pattern, and epidermolysis bullosa acquisita, a disorder affecting tissue anchoring structures.
• ·Erythema multiforme or another acute mucocutaneous reaction: abrupt oral erosions with lip crusting, skin lesions or systemic illness require a different assessment pathway.
• ·Infection: investigate when the appearance, immune status or systemic symptoms support it; redness alone does not establish infection.
• ·Epithelial dysplasia or squamous cell carcinoma: abnormal precancerous cells or oral cancer must be considered in a persistent focal red, ulcerated, firm or enlarging lesion.

Which investigations help, and when is imaging indicated?

Imaging does not diagnose the usual immune-mediated causes of desquamative gingivitis. Do not request panoramic imaging or cone-beam computed tomography solely because the gingiva is peeling.

Use dental radiographs when periodontal bone loss, a tooth-related source or another bony abnormality is suspected. Cross-sectional imaging may be appropriate for a mass, suspected deep extension or significant neck findings, usually directed by the relevant specialist.

Blood tests should answer a clinical question. Targeted antibody tests can support autoimmune blistering diagnoses, but a negative blood result does not exclude mucous membrane pemphigoid. Sampling for infection is appropriate only when infection is a credible differential or complication.

• ·Prioritise tissue diagnosis over imaging for persistent unexplained epithelial peeling.
• ·Investigate systemic illness or nutritional compromise according to the history and examination.
• ·Do not delay urgent eye or airway assessment while awaiting laboratory results.
• ·Do not use imaging as a substitute for biopsy of a suspicious mucosal lesion.

When should you biopsy, and which specimens are needed?

Arrange biopsy for persistent unexplained desquamative gingivitis, suspected autoimmune blistering disease, atypical lichenoid disease or a suspicious focal lesion. If specimen selection or laboratory handling is unfamiliar, refer before sampling; a poorly chosen specimen may require another procedure.

Routine histology examines tissue structure. Direct immunofluorescence, or DIF, identifies immune deposits within tissue. When blistering disease is suspected, these usually require separately collected and separately handled specimens.

For routine histology, select a representative lesion edge containing intact epithelium rather than only a completely eroded centre. For DIF, suitable intact tissue beside a lesion is commonly selected; clinically normal buccal mucosa can also be diagnostically useful in suspected mucous membrane pemphigoid [1].

• ·Discuss the differential, specimen site and transport requirements with the receiving laboratory before biopsy.
• ·Do not place the DIF specimen in routine histology fixative; use the laboratory's specified handling arrangements.
• ·Avoid heavily ulcerated or traumatised tissue for DIF when a suitable intact site is available.
• ·Provide the lesion map, extraoral symptoms and relevant previous treatment history.
• ·If cancer is suspected, obtain representative tissue for histology and use the urgent cancer referral pathway; DIF is not a substitute.

How should histology and immunofluorescence be interpreted?

Histology may show interface inflammation in a lichenoid disorder, a split beneath the epithelium in pemphigoid, or loss of attachment between epithelial cells in pemphigus. These findings must be interpreted with the clinical distribution and immune studies.

DIF may show linear immune deposits along the epithelial basement membrane in pemphigoid-spectrum disease. Pemphigus typically produces intercellular deposits between epithelial cells. A linear pattern alone may not identify the exact blistering disorder, so specialist laboratory interpretation matters.

A negative or nonspecific report does not automatically exclude disease. Sampling an eroded site, tissue damage, unsuitable transport or previous treatment can reduce diagnostic yield. When suspicion remains strong, discuss pathology review, repeat biopsy from another suitable site or additional specialist tests.

• ·Check whether intact epithelium and the relevant tissue interface were present.
• ·Confirm that the laboratory received the correct specimen for each test.
• ·Reconcile conflicting clinical and laboratory findings before assigning a permanent diagnosis.
• ·Do not allow an inconclusive biopsy to postpone referral for eye, airway or cancer warning signs.

Exactly when and where should the patient be referred?

Referral urgency depends on threatened function, systemic illness and cancer suspicion, not simply the extent of gingival redness. The categories below are practical triage decisions; local access and referral pathways determine how urgent assessment is delivered.

Send a concise referral stating the suspected diagnosis, oral sites, symptom trajectory, extraoral findings, oral intake and any biopsy results. Confirm receipt for urgent referrals rather than relying only on a routine appointment request.

• ·Immediately to an emergency department: breathing difficulty, noisy breathing, inability to swallow saliva, rapidly progressive throat symptoms, severe dehydration or serious systemic illness.
• ·Same day to ophthalmology or an emergency eye service: suspected blistering disease with eye pain, redness, light sensitivity or visual change. Do not wait for biopsy confirmation.
• ·Urgently to ENT: new hoarseness or swallowing symptoms with suspected mucous membrane pemphigoid; use emergency care if airway or swallowing safety is compromised.
• ·Promptly, within days rather than after repeated routine dental reviews, to oral medicine and dermatology: suspected pemphigus or pemphigoid, spreading erosions or substantial functional impairment.
• ·Promptly to ophthalmology for baseline assessment: suspected or confirmed mucous membrane pemphigoid without eye symptoms; arrange coordinated follow-up as indicated.
• ·Through the local urgent oral cancer pathway to oral and maxillofacial surgery or a head-and-neck cancer service: an ulcer lasting beyond two weeks, a lump, numbness, unexplained bleeding, induration, or unexplained difficulty opening the mouth or swallowing.
• ·To oral medicine for the next available assessment: persistent unexplained desquamative gingivitis without emergency features. Escalate if symptoms worsen or specialist access is substantially delayed.

What care should follow diagnosis?

Care should address the confirmed mucosal disease and coexisting periodontal inflammation. Gentle plaque control, trauma reduction, dietary support and practical help with oral hygiene can reduce secondary aggravation, but periodontal care alone will not control an autoimmune blistering disorder.

Oral medicine usually coordinates oral-dominant lichenoid disease. Pemphigoid and pemphigus need coordinated oral medicine and dermatology care, with ophthalmology, ENT or other specialists according to the sites involved. Treatment may include local or systemic immune-directed care under the responsible specialist.

Follow-up should document lesion extent, pain, oral intake, oral hygiene and new extraoral symptoms. A changing focal lesion needs fresh assessment rather than automatic attribution to the existing diagnosis.

• ·Use a shared-care plan that names the clinician responsible for disease monitoring.
• ·Give explicit safety-net advice about eye symptoms, breathing changes, swallowing difficulty and persistent focal ulcers.
• ·Arrange nutritional support when eating is significantly affected.
• ·For referrals across Mumbai, Thane, Ambarnath or surrounding areas, select a service with access to appropriate biopsy testing and the required medical specialties.

Which guidance supports this diagnostic approach?

The recommendations above draw on disease-specific guidance and expert consensus rather than a single universal desquamative gingivitis guideline. The consistent principles are clinicopathological correlation, appropriate immune testing, assessment of extraoral sites and specialist-led care.

The emergency triage statements reflect the potential consequences of ocular scarring, airway compromise and suspected malignancy. They should not be interpreted as quoted appointment deadlines from the documents below.

• ·[1] European Academy of Dermatology and Venereology: European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, Parts I and II. Journal of the European Academy of Dermatology and Venereology, 2021. Supports multidisciplinary assessment and appropriate tissue and immune testing.
• ·[2] Diagnosis and management of pemphigus: Recommendations of an international panel of experts. Journal of the American Academy of Dermatology, 2020. Supports combined clinical, histological and immunological diagnosis.
• ·[3] Diagnosis of oral lichen planus: a position paper of the American Academy of Oral and Maxillofacial Pathology. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2016. Supports clinicopathological correlation and continued reassessment.